It may be that Cytodyn is not able to disclose that, but Dr.Pourhassan has stated multiple times that there have been many deaths in s/c CD10, which increases likelihood of statistical significance and of early trial cessation by DSMC.

I have not heard a number floated and I do not believe I have missed a CC or proactive video the last three months.

We may be in a different place in a week.